Bayer Consumer Care (Ex-North America Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Bayer Consumer Care (Ex-North America Rights) General Information

Description

Rights to develop and commercialize ATX-101, a drug for facial fat reduction, outside the US and Canada. ATX-101 is a proprietary injectable formulation of a synthetic version of deoxycholic acid for the reduction of submental fat (double chin).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Other Commercial Services
Corporate Office
  • Peter Merian Strasse 84
  • Post Office Box
  • 4002 Basel
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer Consumer Care (Ex-North America Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer Consumer Care (Ex-North America Rights)‘s full profile, request access.

Request a free trial

Bayer Consumer Care (Ex-North America Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer Consumer Care (Ex-North America Rights)‘s full profile, request access.

Request a free trial

Bayer Consumer Care (Ex-North America Rights) FAQs

  • Where is Bayer Consumer Care (Ex-North America Rights) headquartered?

    Bayer Consumer Care (Ex-North America Rights) is headquartered in Basel, Switzerland.

  • What industry is Bayer Consumer Care (Ex-North America Rights) in?

    Bayer Consumer Care (Ex-North America Rights)’s primary industry is Buildings and Property.

  • Is Bayer Consumer Care (Ex-North America Rights) a private or public company?

    Bayer Consumer Care (Ex-North America Rights) is a Private company.

  • What is the current valuation of Bayer Consumer Care (Ex-North America Rights)?

    The current valuation of Bayer Consumer Care (Ex-North America Rights) is 0000.

  • What is Bayer Consumer Care (Ex-North America Rights)’s current revenue?

    The current revenue for Bayer Consumer Care (Ex-North America Rights) is 000000.

  • Who are Bayer Consumer Care (Ex-North America Rights)’s investors?

    Bayer Consumer Care has invested in Bayer Consumer Care (Ex-North America Rights).

  • When was Bayer Consumer Care (Ex-North America Rights) acquired?

    Bayer Consumer Care (Ex-North America Rights) was acquired on 10-Mar-2014.

  • Who acquired Bayer Consumer Care (Ex-North America Rights)?

    Bayer Consumer Care (Ex-North America Rights) was acquired by Kythera Biopharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »